Recurrent breast cancer
Clinical trials for Recurrent breast cancer explained in plain language.
Never miss a new study
Get alerted when new Recurrent breast cancer trials appear
Sign up with your email to follow new studies for Recurrent breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo tackles Hard-to-Treat breast cancer
Disease control OngoingThis early-stage study tests two drugs, palbociclib and avelumab, together for people with a specific type of advanced breast cancer (AR+ triple negative). The main goals are to find the safest doses and see if the combination can shrink tumors. About 45 participants will take pa…
Matched conditions: RECURRENT BREAST CANCER
Phase 1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a drug combo shrink breast tumors better before surgery?
Disease control OngoingThis phase 3 trial tests whether giving fulvestrant alone or with anastrozole before surgery works better than anastrozole alone for postmenopausal women with estrogen receptor-positive breast cancer. Over 1,400 participants will receive one of these hormone therapies for several…
Matched conditions: RECURRENT BREAST CANCER
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis study tested whether a special PET scan using a radioactive tracer can predict how well patients with advanced HER2-positive breast cancer respond to the drug T-DM1. Ten women with cancer that had spread to other parts of the body received the scan before treatment. The goal…
Matched conditions: RECURRENT BREAST CANCER
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Your genes may decide if breast cancer drug causes joint pain
Knowledge-focused OngoingThis study looks at whether certain genetic variations can predict which women with early-stage breast cancer will stop taking anastrozole, a common hormone therapy, because of joint and muscle pain. Researchers will follow about 1,046 postmenopausal women who are prescribed anas…
Matched conditions: RECURRENT BREAST CANCER
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC